Latest Us Listings News

Brookside Energy reported solid production growth and financial gains in Q3 2025, driven by the Bruins well's full-quarter output and a strategic new area of interest in the Anadarko Basin. The company also initiated a share buy-back and advanced plans for a US listing.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Alliance Nickel has appointed financial advisors to explore a SPAC transaction for a Nasdaq listing, aiming to tap into premium US capital markets for its NiWest Nickel-Cobalt Project. The move follows a robust feasibility study and a strategic partnership with automaker Stellantis.

Alcoa Corporation has announced a quarterly dividend of USD 0.10 per CDI, payable on 21 November 2025, with multiple currency payment options and a 30% withholding tax for non-residents.

Power Minerals Limited is set to list on the US OTCQB market following strong investor interest after acquiring the Gamma Heavy Rare Earths and Uranium Project in California, aiming to boost liquidity and visibility in the US capital markets.

News Corporation has updated its dividend details for the six months ending June 2025, confirming an ordinary unfranked dividend of USD 0.10 per Class A non-voting common stock CDI, payable in both US and Australian dollars.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

BlackRock is reshaping its iShares Future Tech Innovators ETF by narrowing its focus to the 30 largest Nasdaq 100 companies and cutting management fees nearly in half, effective October 15, 2025.

Domain Holdings Australia has officially been acquired by US-based CoStar Group, with shareholders receiving cash payouts and a special dividend. The acquisition triggers a board overhaul and imminent ASX delisting.

Argent BioPharma has signed a binding term sheet to acquire key assets from AusCann Group Holdings, significantly expanding its clinical pipeline, intellectual property, and European manufacturing and distribution capabilities ahead of a planned US stock exchange listing.

ResMed Inc has updated the foreign exchange rate for its forthcoming dividend payable to ASX-listed CDIs, setting the Australian dollar payout at 9.24 cents per CDI. This adjustment reflects the latest USD to AUD exchange rate and carries important tax implications for investors.